Vivek Ramaswamy
CIK 1635075 · Principal Executive Officer · last filed 2025-12-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.85B
Companies
4
Total Filings
33
Lifetime Open-Market Net
-$223.71M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | 10%+ Owner | 47,011,612 | $37.37 | $1.76B | -$193.16M | 10 | 2025-12-15 |
| ASST | 10%+ Owner | 7,112,837 | $12.80 | $91.04M | $1.25M | 2 | 2025-11-07 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 54,730,523 | $2.75 | $150.51M | -$31.80M | 4 | 2023-08-29 |
| ABUS | Director | — | $4.84 | — | $0 | 4 | 2018-06-22 |
Recent Filings · Page 3 of 4
33 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-29 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | +39,022 | -$536.5K | EDGAR |
| 2023-08-28 | ROIV | Notice (144) | −86,714 | -$966.0K | EDGAR |
| 2023-08-01 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | +90,034 | -$868.9K | EDGAR |
| 2023-07-28 | ROIV | Notice (144) | −166,057 | -$1.79M | EDGAR |
| 2023-05-31 | ROIV | Notice (144/A) | −382,203 | -$3.56M | EDGAR |
| 2023-05-31 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | +192,256 | -$1.73M | EDGAR |
| 2023-05-30 | ROIV | Notice (144) | −382,203 | -$355.83M | EDGAR |
| 2023-02-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Sell (S) | −4,000,000 | -$31.80M | EDGAR |
| 2018-06-22 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2017-06-23 | ABUS | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.